News Focus
News Focus
icon url

McMagyar

06/28/20 6:05 PM

#256708 RE: baltimorebullet #256707

Good find..
I think they mean PDD ..
But maybe./
icon url

bennyboy1

06/28/20 6:09 PM

#256710 RE: baltimorebullet #256707

BB: Last I remember Dr Missling said we could handle Rett but would need to partner for PDD. Perhaps the worm has turned. We may be looking to keep more revenue for a multitude of indications around the corner?
icon url

TTTav66

06/28/20 6:14 PM

#256712 RE: baltimorebullet #256707

Nice window into the company’s current thinking here — definitely evolved from previous statements.

Thanks to Jager997 for sharing the convo.
icon url

bb8675309

06/28/20 6:20 PM

#256714 RE: baltimorebullet #256707

Just a thought. MJFF and Anavex maybe taking A2-73 to market in a joint effort for PDD. Possible. IMO

Also Longtermbeliever may be partnering. He has more shares than some instys. Hold on Loooongs. Lol.
icon url

ExtremelyBullishZig

06/28/20 10:40 PM

#256734 RE: baltimorebullet #256707

What he means by it being a good summer is that there will be some kind of results, obviously.

Good or bad is not known and cannot be known at this point for legal reasons. His answers are how IR would answer... regardless of the company...
icon url

jimmy_mcyoloswag

06/29/20 6:18 AM

#256743 RE: baltimorebullet #256707

Yep, new nugget of information. Was definitely Rett only and partner the rest in the last call.
icon url

anders2211

06/29/20 9:28 AM

#256760 RE: baltimorebullet #256707

" We feel that we can take Rett Syndrome and Parkinson’s treatment to market ".



Ofcourse IR does know as much as any of us but it does boost a hell of a lot of confidence. Why say this if you are not sure the drug will be approved